Fundraiser for ME/CFS sufferers for a study with the drug BC007

EXPANSION OF STUDY - Through private donations and politics 

(As of April 6th, 2022)

 

We will continue to collect until the end of May 2022, also with the funding amount of €800,000 decided by Bavarian state politics on April 6th, 2022. We would like to thank you very much for this and with further donations we could implement some expansions of the study (e.g. further doses of the drug BC007 if the autoantibodies reappear, longer course of the study, extension of the follow-up observations, supplementation of examinations and follow-up examinations). We have already achieved a great deal and look forward to your donations, which we urgently need. 

 

Many many thanks!

 

The #fundraisingbc007MEcfs team

 

For more information see the FAQ.

Donation barometer

donations received
125 EUR

The first 100,000 Euros that are needed for the study at the Erlangen University Hospital for the treatment of ME/CFS: Alexander Graef, first chairman of the Brückeverbindet association (left), handing over the check to the molecular medicine specialist and ophthalmologist PD Dr. Dr. Bettina Hohberger and Prof. Dr. Werner G. Daniel (Chairman of the Board/Research Foundation Medicine). Photo: Kerstin Bönisch/ Erlangen University Hospital

Donating is NOT possible anymore!

Current:
Target:

The non-profit association Brückeverbindet e.V. collects the donations for this project on a specially set up account. Your donation goes 100% to the research project of the UNI-Erlangen to include ME/CFS sufferers in the study with the promising drug BC007.

en_GBEnglish